OVERSEA CHINESE BANKING Corp Ltd Makes New $32.40 Million Investment in Agilent Technologies, Inc. $A

Key Points

• Oversea Chinese Banking Corp Ltd acquired 243,882 Agilent Technologies shares worth approximately $32.4 million, making up 0.7% of its portfolio and 0.09% of Agilent’s outstanding shares.
• Agilent reported quarterly EPS of $1.49, exceeding estimates by $0.08, while revenue rose 10% year over year to $1.83 billion. The company guided for fiscal 2026 EPS of $6.00–$6.10.
• Analysts maintain a generally positive view, with a consensus “Moderate Buy” rating and an average price target of $160.24; the stock recently traded near its 52-week high at $156.50.

OVERSEA CHINESE BANKING Corp Ltd acquired a new position in Agilent Technologies, Inc. (NYSE:A - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 243,882 shares of the medical research company's stock, valued at approximately $32,395,000. Agilent Technologies accounts for 0.7% of OVERSEA CHINESE BANKING Corp Ltd's holdings, making the stock its 26th largest holding. OVERSEA CHINESE BANKING Corp Ltd owned 0.09% of Agilent Technologies at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Core Wealth Advisors LLC bought a new stake in shares of Agilent Technologies during the 4th quarter valued at $26,000. SHP Wealth Management bought a new position in shares of Agilent Technologies in the 4th quarter worth about $26,000. Navalign LLC purchased a new position in Agilent Technologies during the 4th quarter valued at about $27,000. Cedar Mountain Advisors LLC purchased a new position in Agilent Technologies during the 1st quarter valued at about $27,000. Finally, MV Capital Management Inc. bought a new stake in Agilent Technologies during the fourth quarter worth about $28,000.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $156.50 on Friday. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.27. The firm's 50-day moving average is $136.98 and its 200 day moving average is $126.00. The stock has a market cap of $44.20 billion, a price-to-earnings ratio of 31.43, a PEG ratio of 2.75 and a beta of 1.25. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62.

Agilent Technologies (NYSE:A - Get Free Report) last issued its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.08. The business had revenue of $1.83 billion during the quarter, compared to analysts' expectations of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business's revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period in the previous year, the company earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Sell-side analysts anticipate that Agilent Technologies, Inc. will post 6.03 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on A shares. Robert W. Baird upped their price objective on shares of Agilent Technologies from $155.00 to $156.00 and gave the stock an "outperform" rating in a report on Tuesday, May 26th. Piper Sandler started coverage on shares of Agilent Technologies in a report on Thursday, June 11th. They set a "neutral" rating and a $150.00 target price for the company. Jefferies Financial Group initiated coverage on Agilent Technologies in a research report on Thursday, July 9th. They issued a "hold" rating and a $135.00 price target on the stock. Wells Fargo & Company cut their price target on Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating on the stock in a research note on Thursday, May 28th. Finally, Royal Bank Of Canada began coverage on Agilent Technologies in a research report on Wednesday, May 27th. They set an "outperform" rating and a $153.00 price objective for the company. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $160.24.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source